Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE)

Show simple item record

dc.contributor.author Healy, Patricia
dc.contributor.author Gordijn, Sanne
dc.contributor.author Ganzevoort, Wessel
dc.contributor.author Beune, Irene
dc.contributor.author Baschat, Ahmet
dc.contributor.author Khalil, Asma
dc.contributor.author Kenny, Louise
dc.contributor.author Bloomfield, Frank
dc.contributor.author Daly, Mandy
dc.contributor.author Papageorghiou, Aris
dc.contributor.author Devane, Declan
dc.date.accessioned 2019-11-25T10:38:01Z
dc.date.available 2019-11-25T10:38:01Z
dc.date.issued 2018-08-22
dc.identifier.citation Healy, P., Gordijn, S., Ganzevoort, W., Beune, I., Baschat, A., Khalil, A., Kenny, L., Bloomfield, F., Daly, M., Papageorghiou, A. and Devane, D., 2018. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE). Trials, 19(1), (451). DOI: 10.1186/s13063-018-2819-9 en
dc.identifier.volume 19 en
dc.identifier.issued 1 en
dc.identifier.startpage 1 en
dc.identifier.endpage 7 en
dc.identifier.uri http://hdl.handle.net/10468/9211
dc.identifier.doi 10.1186/s13063-018-2819-9 en
dc.description.abstract Foetal growth restriction (FGR) refers to a foetus that does not reach its genetically predetermined growth potential. It is well recognised that growth-restricted foetuses are at increased risk of stillbirth, foetal compromise, early neonatal death and neonatal morbidity. Later in life, they are prone to health problems, including increased risk of cardiovascular diseases and neurodevelopmental disorders. Interventions for preventing and treating FGR have been studied in many trials, but evidence is often difficult to synthesise and compare because of differences in the selection and definition of outcomes. To enable future trials to measure similar, meaningful outcomes, we are developing two core outcome sets (COS) – one for prevention and the other for treatment of FGR. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BioMed Central en
dc.relation.uri https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-2819-9
dc.rights © The Author(s) 2018 en
dc.rights.uri https://creativecommons.org/licenses/by/4.0/ en
dc.subject Core outcome sets en
dc.subject Delphi en
dc.subject Methodology en
dc.subject Foetal growth restriction en
dc.subject Pregnancy en
dc.title Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE) en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Louise Kenny, The Irish Centre for Fetal and Neonatal Translational Research (INFANT), University College Cork, Cork, Ireland. +353-21-490-3000 Email: l.kenny@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.contributor.funder Health Research Board, Ireland en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Trials en
dc.internal.IRISemailaddress l.kenny@ucc.ie en
dc.identifier.articleid 451 en
dc.identifier.eissn 1745-6215


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2018 Except where otherwise noted, this item's license is described as © The Author(s) 2018
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement